| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743530 | Null | 0.000497857311992523 | 0.43177931 |
| NSC 114512 | Null | 0.000497857311992526 | 0.52680308 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.000497857311992526 | 0.46671041 |
| NSC 671883 | Null | 0.000584785790823222 | 0.53196647 |
| NSC 341196 | Null | 0.000659507126432928 | 0.48341294 |
| NSC 646122 | Null | 0.000659507126432928 | 0.44415996 |
| NSC 72942 | DL-Noformicin | 0.000659507126432928 | -0.40465713 |
| NSC 632573 | Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) | 0.000706163530262832 | 0.39410209 |
| NSC 645164 | Null | 0.000706163530262832 | 0.56293289 |
| NSC 659687 | 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride | 0.000706163530262832 | 0.24544072 |